Modern Healthcare News
 
RSS feed

AstraZeneca news and information

Information
China fines GlaxoSmithKline $492M for bribery
By Associated Press | September 19, 2014
Drugmaker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China, the biggest such penalty ever imposed by a Chinese court.
FULL STORY »
 

Information
Pfizer's 2Q profit sinks 79% but tops forecasts
By Associated Press | July 29, 2014
Pfizer's second-quarter earnings plunged 79% from last year, when the world's second-largest drugmaker booked a $10 billion-plus gain from a business spinoff.
FULL STORY »
 

Information
Merck 2Q profit more than doubles
By Associated Press | July 29, 2014
A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, improve its profit forecast and top analysts' expectations.
FULL STORY »
 

Information
Antiviral-drug maker fights pediatricians' new advice
By Associated Press | July 28, 2014
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.
FULL STORY »
 

Magazine
Tax reform fears driving Big Pharma mergers
By Beth Kutscher | July 19, 2014 | Print Magazine Print Magazine Subscription Details
The rumblings that corporate tax reform will close favorable loopholes for pharmaceutical and biotechnology companies are getting louder, fueling a rush of high-dollar cross-border deals.
FULL STORY »
 


Advertisement | View Media Kit

Information
New drugs may make a dent in lung, ovarian cancer
By Associated Press | May 31, 2014
New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost.
FULL STORY »
 

Information
Pfizer withdraws spurned offer for AstraZeneca
By Associated Press | May 26, 2014
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
FULL STORY »
 

Magazine
Drug prices spotlighted in AstraZeneca deal
By Beth Kutscher | May 24, 2014 | Print Magazine Print Magazine Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from Pfizer to create the world's largest pharmaceutical company.
FULL STORY »
 

News
AstraZeneca holding firm against Pfizer's advances
By Beth Kutscher | May 23, 2014 | Basic Web Basic Web Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from rival Pfizer to create the world's largest pharmaceutical company. The record-setting offer is just one of a slew of mega-deals this year in the pharmaceutical and...
FULL STORY »
 

Information
AstraZeneca rejects Pfizer's 'final' $116B bid
By USA Today | May 19, 2014
British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.